6317101191

Kiodowska-Duda GA, Samelska JA. Opala GM.

[Polymorphism of N-acetyltransfcrasc-2 and pathogenesis of neoplastic diseases]

Wiad Lek. 2005;58(3-4):212-7. Review. Polish.

IF: brak KBN: 5

9.

Białecka M, Hui S, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.

Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson's disease.

Neurosci Lett. 2005 Dec 16;390( 1): 1-3.

IF: 1,898 KBN: 15

10.

Opala G, Krzystanek E, Siuda J, Pilch-Kowalczyk J.

[Melkersson-Rosenthal syndrome as a rare cause of recurrent facial nerve palsy]

Neurol Neurochir Pol. 2005 Jul-Aug;39(4):335-8. Polish.

IF: brak KBN: 5

11.

Krzystanek E, Opala G.

[Teleneurology: a new form of physician—patient communication]

Wiad Lek. 2005;58(l-2):21-4. Pofish.

IF: brak KBN: 5

12.

Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J. Dąbrowską E, Kubisiak M, Klodowska-Duda G, Opala G.

Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.

Eur Neurol. 2005;53(2):68-73.

IF: 1,056 KBN: 15

13.

Białecka M, Droździk M, Klodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B. Opala G, Stankiewicz J.

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.

Acta Neurol Scand. 2004 Oct;l 10(4):260-6.

IF: 1.712 KBN: 10

14.

Jasińska-Myga B. Opala G, Ochudlo S, Tustanowski J.

[Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia]

Wiad Lek. 2004;57(l-2):20-4. Polish.

IF: brak KBN: 5

15.

Ochudlo S, Opala G.

3